Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinomaLijie Ma(Fudan University), Qiang Gao(Fudan University)TheranosticsJanuary 1, 201810.7150/thno.28742Cited by 61SaveCiteExport RISWatch citationsRelated PapersGenome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma|Autophagy|2022|90Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma|Cancer Discovery|2022|76